Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Orthopedic

PUBLISHER: Allied Market Research | PRODUCT CODE: 1193068

Cover Image

PUBLISHER: Allied Market Research | PRODUCT CODE: 1193068

Artificial Tendons and Ligaments Market By Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, Others), By End users (Hospitals and Clinics, ASCs): Global Opportunity Analysis and Industry Forecast, 2021-2031

PUBLISHED:
PAGES: 240 Pages
DELIVERY TIME: 2-3 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Cloud Access (Single User License)
USD 3570
PDF (Business License)
USD 5730
PDF (Enterprise User License) & Excel (Data Pack) & Free Update
USD 9600

Add to Cart

Description

Table of Contents

List of Tables

The artificial tendons and ligaments market was valued at $64.3 million in 2021 and is estimated to reach $165.7 million by 2031, growing at a CAGR of 10.1% from 2022 to 2031.

Artificial tendons and ligament tools intended to reinforce or replace natural tendons, and ligaments, including any necessary fixing devices. Artificial tendons are also used to treat torn and damaged tendons. The damaged area may feel weak or painful. Tendons are soft, band-like tissues that connect muscles to bone. Ligaments are fibrous connective tissue that connects one bone to another bone. When the muscles contract, the tendons pull the bones and cause the joints to move. When tendon damage occurs, movement may be seriously limited. The joints that are most commonly affected by tendon injuries are the shoulders, elbows, ankles, thighs, knees, and fingers. According to the American Academy of Orthopedic Surgeons, "jersey finger" is one of the most common sports injuries affecting the tendons. Tendon damage can also occur in rheumatoid arthritis, an inflammatory disease of the joints. Rheumatoid arthritis can involve the tendons, causing them to tear.

The damaged tendon and ligaments can be treated by replacement from artificial tendons and ligaments. The replacement of artificial tendons and ligaments is done to bring back normal movement to a joint. In tendons and ligament surgery, a surgeon will make one or more small incisions (cuts) in the skin over the damaged tendon, replace the damaged tendon or ligament, and sew the torn ends of the tendon together. After, check the surrounding tissue to make sure no other injuries, such as injury to the blood vessels or nerves have occurred, and then close the incision and cover the area with sterile bandages or dressings. After surgery, the surgeon will suggest immobilizing or splinting the joint to allow the tendon to heal.

Major factors driving the growth of the artificial tendons and ligaments market include an increase in the geriatric population, a rise in sports-related injuries such as sprains, strains, tendinitis, and contusions, the surge in incidences of tendon and wrist injuries, and an increase in interest in other workouts and physical activities among children and adults. For instance, according to a John Hopkins Medicine article in 2019, 30 million individuals participate in organized sports, resulting in more than 3.5 million sports injuries annually in the U.S. alone, with sprains and strains.

Tendon injury mostly occurs during hard physical work out such as rowing, heavy weight lifting, occupation activities such as window washing, woodwork, some assembly line works, and sports activities such as football, basketball, pedal cycling, soccer, ice or roller skating, and skateboarding. Artificial muscles and tendons for knee, ankle, and tendon reinforcement will also become increasingly popular due to a growing propensity for minimally invasive procedures, government activities to raise awareness about sports injuries, and developments in surgical methods.

Moreover, the surge in accidents causes tendons and ligament damage, particularly road accidents leading to an increase in the number of artificial tendons and ligament surgeries, thus fueling the growth of the artificial tendons and ligament market. For instance, according to Accident and Emergency (A&E) statistics, 24.8 million sports injuries were recorded in 2019, an increase of 2% compared with 2018. Furthermore, an increase in demand for minimally invasive procedures propels the adoption of artificial tendons and ligaments product.

In addition, technological advancements; the launch of various products; strategies among key players such as acquisition, collaboration, and agreement drive the growth of the artificial tendons and ligaments market

For instance, in 2021, Striker launched its Citrelock tendon fixation devices system for orthopedic surgical applications. The new system provides surgeons with a differentiated design via a tendon thread featuring a resorbable technology, known as Citregen, which has unique chemical and mechanical properties for orthopedic surgical applications. The launch of Citrelock will help the company to strengthen its orthopedics portfolio.

However, the lack of acceptance for biological products and the lack of appropriate knowledge regarding products among physicians and surgeons limit the market growth. Stricter regulatory standards and high costs for artificial tendons and ligament products also restrain market growth. Furthermore, the healthcare business is predicted to witness growth, owing to a rise in the prevalence of tendonitis and obesity, an increase in R&D investments in drug discovery & development, and a rise in awareness regarding physical fitness and workout. This is anticipated to offer remunerative opportunities for key players to invest in the market during the forecast period.

The artificial tendons and ligaments market is segmented on the basis of application, end user, and region. On the basis of application, the market is classified into knee Injuries, Shoulder Injuries, foot and ankle injuries, and others. Depending on the end user, it is segmented into hospitals and clinics, and ambulatory surgery centers. The artificial tendons and ligaments market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Major players profiled in the report are Artelon, Arthrex, Inc., Corin Group, Enovis, Exactech, Inc., FX-Global Inc., Group FH Communication, Integra Lifesciences, Neoligaments, Stryker Corporation.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the artificial tendons and ligaments market analysis from 2021 to 2031 to identify the prevailing artificial tendons and ligaments market opportunities.

Market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.

An in-depth analysis of the artificial tendons and ligaments market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes analysis of the regional as well as global artificial tendons and ligaments market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Application

  • Foot and Ankle Injuries
  • Knee Injuries
  • Shoulder Injuries
  • Others

By End users

  • Hospitals and Clinics
  • ASCs

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA
  • Key Market Players
    • Arthrex, Inc.
    • fx solutions
    • Orthomed S.A.S
    • Neoligaments
    • Artelon
    • Corin Groups
    • Mathys AG
    • F H Orthopedics
    • Integra Lifesciences Corporation
    • Stryker Corporation
Show more
Product Code: A10245

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Knee Injuries
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Shoulder Injuries
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country
  • 4.4 Foot and Ankle Injuries
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market share analysis by country
  • 4.5 Others
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market share analysis by country

CHAPTER 5: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Hospitals and Clinics
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 ASCs
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country

CHAPTER 6: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Application
    • 6.2.3 North America Market size and forecast, by End users
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Key market trends, growth factors and opportunities
      • 6.2.4.1.2 Market size and forecast, by Application
      • 6.2.4.1.3 Market size and forecast, by End users
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Key market trends, growth factors and opportunities
      • 6.2.4.2.2 Market size and forecast, by Application
      • 6.2.4.2.3 Market size and forecast, by End users
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Key market trends, growth factors and opportunities
      • 6.2.4.3.2 Market size and forecast, by Application
      • 6.2.4.3.3 Market size and forecast, by End users
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Application
    • 6.3.3 Europe Market size and forecast, by End users
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Key market trends, growth factors and opportunities
      • 6.3.4.1.2 Market size and forecast, by Application
      • 6.3.4.1.3 Market size and forecast, by End users
      • 6.3.4.2 France
      • 6.3.4.2.1 Key market trends, growth factors and opportunities
      • 6.3.4.2.2 Market size and forecast, by Application
      • 6.3.4.2.3 Market size and forecast, by End users
      • 6.3.4.3 UK
      • 6.3.4.3.1 Key market trends, growth factors and opportunities
      • 6.3.4.3.2 Market size and forecast, by Application
      • 6.3.4.3.3 Market size and forecast, by End users
      • 6.3.4.4 Italy
      • 6.3.4.4.1 Key market trends, growth factors and opportunities
      • 6.3.4.4.2 Market size and forecast, by Application
      • 6.3.4.4.3 Market size and forecast, by End users
      • 6.3.4.5 Spain
      • 6.3.4.5.1 Key market trends, growth factors and opportunities
      • 6.3.4.5.2 Market size and forecast, by Application
      • 6.3.4.5.3 Market size and forecast, by End users
      • 6.3.4.6 Rest of Europe
      • 6.3.4.6.1 Key market trends, growth factors and opportunities
      • 6.3.4.6.2 Market size and forecast, by Application
      • 6.3.4.6.3 Market size and forecast, by End users
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Application
    • 6.4.3 Asia-Pacific Market size and forecast, by End users
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 Japan
      • 6.4.4.1.1 Key market trends, growth factors and opportunities
      • 6.4.4.1.2 Market size and forecast, by Application
      • 6.4.4.1.3 Market size and forecast, by End users
      • 6.4.4.2 China
      • 6.4.4.2.1 Key market trends, growth factors and opportunities
      • 6.4.4.2.2 Market size and forecast, by Application
      • 6.4.4.2.3 Market size and forecast, by End users
      • 6.4.4.3 India
      • 6.4.4.3.1 Key market trends, growth factors and opportunities
      • 6.4.4.3.2 Market size and forecast, by Application
      • 6.4.4.3.3 Market size and forecast, by End users
      • 6.4.4.4 Australia
      • 6.4.4.4.1 Key market trends, growth factors and opportunities
      • 6.4.4.4.2 Market size and forecast, by Application
      • 6.4.4.4.3 Market size and forecast, by End users
      • 6.4.4.5 South Korea
      • 6.4.4.5.1 Key market trends, growth factors and opportunities
      • 6.4.4.5.2 Market size and forecast, by Application
      • 6.4.4.5.3 Market size and forecast, by End users
      • 6.4.4.6 Rest of Asia-Pacific
      • 6.4.4.6.1 Key market trends, growth factors and opportunities
      • 6.4.4.6.2 Market size and forecast, by Application
      • 6.4.4.6.3 Market size and forecast, by End users
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Application
    • 6.5.3 LAMEA Market size and forecast, by End users
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Brazil
      • 6.5.4.1.1 Key market trends, growth factors and opportunities
      • 6.5.4.1.2 Market size and forecast, by Application
      • 6.5.4.1.3 Market size and forecast, by End users
      • 6.5.4.2 South Africa
      • 6.5.4.2.1 Key market trends, growth factors and opportunities
      • 6.5.4.2.2 Market size and forecast, by Application
      • 6.5.4.2.3 Market size and forecast, by End users
      • 6.5.4.3 Saudi Arabia
      • 6.5.4.3.1 Key market trends, growth factors and opportunities
      • 6.5.4.3.2 Market size and forecast, by Application
      • 6.5.4.3.3 Market size and forecast, by End users
      • 6.5.4.4 Rest of LAMEA
      • 6.5.4.4.1 Key market trends, growth factors and opportunities
      • 6.5.4.4.2 Market size and forecast, by Application
      • 6.5.4.4.3 Market size and forecast, by End users

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 Arthrex, Inc.
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 fx solutions
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 Orthomed S.A.S
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 Neoligaments
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 Artelon
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 Corin Groups
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 Mathys AG
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 F H Orthopedics
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Integra Lifesciences Corporation
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 Stryker Corporation
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments
Show more
Product Code: A10245

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR KNEE INJURIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR KNEE INJURIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR SHOULDER INJURIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR SHOULDER INJURIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR FOOT AND ANKLE INJURIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR FOOT AND ANKLE INJURIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR ASCS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR ASCS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. NORTH AMERICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. NORTH AMERICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. NORTH AMERICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. U.S. ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. U.S. ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. CANADA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. CANADA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. MEXICO ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. MEXICO ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. GERMANY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. GERMANY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. FRANCE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. FRANCE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. UK ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. UK ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. ITALY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. ITALY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. SPAIN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. SPAIN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. REST OF EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. REST OF EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. JAPAN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. JAPAN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. CHINA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. CHINA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. INDIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. INDIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. AUSTRALIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. AUSTRALIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. SOUTH KOREA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. SOUTH KOREA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. REST OF ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. REST OF ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. BRAZIL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. BRAZIL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. SOUTH AFRICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. SOUTH AFRICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. SAUDI ARABIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. SAUDI ARABIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. REST OF LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. REST OF LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66.ARTHREX, INC.: COMPANY SNAPSHOT
  • TABLE 67.ARTHREX, INC.: OPERATING SEGMENTS
  • TABLE 68.ARTHREX, INC.: PRODUCT PORTFOLIO
  • TABLE 69.ARTHREX, INC.: NET SALES
  • TABLE 70.ARTHREX, INC.: KEY STRATERGIES
  • TABLE 71.FX SOLUTIONS: COMPANY SNAPSHOT
  • TABLE 72.FX SOLUTIONS: OPERATING SEGMENTS
  • TABLE 73.FX SOLUTIONS: PRODUCT PORTFOLIO
  • TABLE 74.FX SOLUTIONS: NET SALES
  • TABLE 75.FX SOLUTIONS: KEY STRATERGIES
  • TABLE 76.ORTHOMED S.A.S: COMPANY SNAPSHOT
  • TABLE 77.ORTHOMED S.A.S: OPERATING SEGMENTS
  • TABLE 78.ORTHOMED S.A.S: PRODUCT PORTFOLIO
  • TABLE 79.ORTHOMED S.A.S: NET SALES
  • TABLE 80.ORTHOMED S.A.S: KEY STRATERGIES
  • TABLE 81.NEOLIGAMENTS: COMPANY SNAPSHOT
  • TABLE 82.NEOLIGAMENTS: OPERATING SEGMENTS
  • TABLE 83.NEOLIGAMENTS: PRODUCT PORTFOLIO
  • TABLE 84.NEOLIGAMENTS: NET SALES
  • TABLE 85.NEOLIGAMENTS: KEY STRATERGIES
  • TABLE 86.ARTELON: COMPANY SNAPSHOT
  • TABLE 87.ARTELON: OPERATING SEGMENTS
  • TABLE 88.ARTELON: PRODUCT PORTFOLIO
  • TABLE 89.ARTELON: NET SALES
  • TABLE 90.ARTELON: KEY STRATERGIES
  • TABLE 91.CORIN GROUPS: COMPANY SNAPSHOT
  • TABLE 92.CORIN GROUPS: OPERATING SEGMENTS
  • TABLE 93.CORIN GROUPS: PRODUCT PORTFOLIO
  • TABLE 94.CORIN GROUPS: NET SALES
  • TABLE 95.CORIN GROUPS: KEY STRATERGIES
  • TABLE 96.MATHYS AG: COMPANY SNAPSHOT
  • TABLE 97.MATHYS AG: OPERATING SEGMENTS
  • TABLE 98.MATHYS AG: PRODUCT PORTFOLIO
  • TABLE 99.MATHYS AG: NET SALES
  • TABLE 100.MATHYS AG: KEY STRATERGIES
  • TABLE 101.F H ORTHOPEDICS: COMPANY SNAPSHOT
  • TABLE 102.F H ORTHOPEDICS: OPERATING SEGMENTS
  • TABLE 103.F H ORTHOPEDICS: PRODUCT PORTFOLIO
  • TABLE 104.F H ORTHOPEDICS: NET SALES
  • TABLE 105.F H ORTHOPEDICS: KEY STRATERGIES
  • TABLE 106.INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
  • TABLE 107.INTEGRA LIFESCIENCES CORPORATION: OPERATING SEGMENTS
  • TABLE 108.INTEGRA LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
  • TABLE 109.INTEGRA LIFESCIENCES CORPORATION: NET SALES
  • TABLE 110.INTEGRA LIFESCIENCES CORPORATION: KEY STRATERGIES
  • TABLE 111.STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 112.STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 113.STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 114.STRYKER CORPORATION: NET SALES
  • TABLE 115.STRYKER CORPORATION: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.ARTIFICIAL TENDONS AND LIGAMENTS MARKET SEGMENTATION
  • FIGURE 2.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031
  • FIGURE 3.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.ARTIFICIAL TENDONS AND LIGAMENTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,BY APPLICATION,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF KNEE INJURIES ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SHOULDER INJURIES ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF FOOT AND ANKLE INJURIES ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OTHERS ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
  • FIGURE 17.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,BY END USERS,2021(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ASCS ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
  • FIGURE 20.ARTIFICIAL TENDONS AND LIGAMENTS MARKET BY REGION,2021
  • FIGURE 21.U.S. ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 22.CANADA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 23.MEXICO ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 24.GERMANY ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 25.FRANCE ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 26.UK ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 27.ITALY ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 28.SPAIN ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 29.REST OF EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 30.JAPAN ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 31.CHINA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 32.INDIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 33.AUSTRALIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 34.SOUTH KOREA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 36.BRAZIL ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 37.SOUTH AFRICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 38.SAUDI ARABIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 39.REST OF LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
  • FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 43.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 44.COMPETITIVE DASHBOARD
  • FIGURE 45.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 46.ARTHREX, INC..: NET SALES ($MILLION)
  • FIGURE 47.FX SOLUTIONS.: NET SALES ($MILLION)
  • FIGURE 48.ORTHOMED S.A.S.: NET SALES ($MILLION)
  • FIGURE 49.NEOLIGAMENTS.: NET SALES ($MILLION)
  • FIGURE 50.ARTELON.: NET SALES ($MILLION)
  • FIGURE 51.CORIN GROUPS.: NET SALES ($MILLION)
  • FIGURE 52.MATHYS AG.: NET SALES ($MILLION)
  • FIGURE 53.F H ORTHOPEDICS.: NET SALES ($MILLION)
  • FIGURE 54.INTEGRA LIFESCIENCES CORPORATION.: NET SALES ($MILLION)
  • FIGURE 55.STRYKER CORPORATION.: NET SALES ($MILLION)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!